MCAZ

Circular 4 of 2024 – Implementation Plan for Re-Registration of Human Allopathic Medicines – Extension of Re-Registration Fee Waiver

Circular 4 of 2024 – Implementation Plan for Re-Registration of Human Allopathic Medicines – Extension of Re-Registration Fee Waiver
Circular 4 of 2024 – Implementation Plan for Re-Registration of Human Allopathic Medicines – Extension of Re-Registration Fee Waiver
93 Downloads
Size: 729KB